News > NHIA News > NHIA Receives Honor from NewYorkBIO

Press Release

NHIA Receives Honor from NewYorkBio

NHIA Receives Honor from NewYorkBIO

October 3, 2022 – At its Annual Meeting on September 28, The National Home Infusion Association (NHIA) was honored as a “COVID Hero of New York” by NewYorkBIO, a group that brings together nearly 300 of the state’s bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercialization.

The COVID Heroes of New York awards showcase members of NewYorkBIO who were at “ground zero” when the pandemic swept the United States and pulled together to keep Americans and America’s health care workforce safe. The award was presented to NHIA on behalf of its member pharmacies that participated in a pilot program to administer the life-saving monoclonal antibodies to nursing home residents and staff at the beginning of the pandemic. Infusion pharmacies track and report patient outcomes, which helped the association secure Medicare reimbursement for home administration of monoclonals to patients for whom clinic-based infusions are not feasible or clinically appropriate.

“NewYorkBIO was pleased to honor a number of individuals as COVID Heroes. I am in awe of the work that Connie and her colleagues at NHIA did to ensure that patients had access to the COVID treatments they needed in a safe environment like home, including nursing homes,” said Jennifer Hawks Bland, CEO NewYorkBIO.

Related Posts

HHS Secretary Kennedy Supports Home Infusion at House E&C Hearing

NHIA applauds Secretary Kennedy’s recent statement in support of improving access to home infusion services for Medicare beneficiaries. We agree with his sentiment that commonsense reforms to Medicare – like home infusion – will save taxpayer dollars while improving access to care, especially for rural and elderly patients. We stand ready to work with the Secretary and HHS to remedy the current lack of coverage for home infusion therapies.

Read More »

NHIA Comments on MTF for 2026 and 2027

NHIA commented on CMS’s Information Collection Request (ICR) regarding the Medicare Transaction Facilitator (MTF) that will be used in facilitating negotiated prices under the Medicare Drug Price Negotiation program.

Read More »